Early Access — free while we kick the tires
EdgarHawk

Huber Martin H. Jr.

Director

Director
1 filing analyzed · 1 company · Latest 2025-05-19

Never miss a filing from Huber Martin H. Jr.

Watch this insider and we'll alert you the moment they file — at any company.

Companies

Company Buys Sells Direction
Syndax Pharmaceuticals Inc SNDX 1 0 Net buying

Activity

May 2025
high
Buy
5,000 shares
$44,950
Significance 7/10

Director Martin H. Huber Jr. buys 5,000 SNDX shares at $8.99; 3 other insiders also bought within 14 days amid -36.4% 90-day decline.

Director Martin H. Huber Jr. purchased 5,000 shares at $8.99 on 2025-05-19, increasing his holdings to 79,000 shares from 74,000 shares. This transaction occurs within a broader insider buying cluster: 3 other insiders also purchased shares within the past 14 days. Notably, this activity unfolds against a backdrop of significant price deterioration—the stock has declined 36.4% over the past 90 days and is -62.5% from its 52-week high of $24.81. The company remains unprofitable with a net loss of $84,846,000.00 against quarterly revenue of $20,042,000.00, making the timing and magnitude of this coordinated buying pattern noteworthy for understanding insider sentiment relative to current valuation and operational performance.

Related insiders